GAD1 and Anxiety: Results from Model 1 indicate that on average, clients reported subclinical levels of anxiety at the time of treatment episode closure (b0 = 6.10), and the average trajectory suggested an approximately b1 = 0.12 units weekly increase in GAD-7 post-treatment that became flatter over time (b2 = −0.002).